Search

The article discusses best practices for sunscreen use in various pediatric patients and the current ultraviolet (UV)-A/UV-B filters that are available. Cited methods for sunscreen application in different pediatric patients, the frequency of sunscreen reapplication, and definitions and explanations for common terms used in sunscreen labels.

The article discusses the highlights of the panel discussion, titled Advancements in Psoriasis Care: Navigating Emerging Therapies and Guidelines. Topic include complexity of treatment regimens and the enhancement of patient-friendly adherence strategies, steroid phobia and attitudes, treatment guidelines, needs of patients with skin of color, long-term safety and efficacy of oral treatments, combining of topicals with systemic therapies, and tailoring of treatment to patient needs.

The article presents trending dermatologic studies. They include "Causal Effects of Lipids-Related Metabolites on Androgenic Alopecia: A Mendelian Randomization Study," "A Cross-sectional Review of Contact Allergens in Popular Self-Tanning Products," and "Real-World Experience of Vitiligo Patients: A Retrospective Chart Review."

The article commemorates the 45th anniversary of the magazine. It presents a chronology of milestones in the history of dermatology including advancements in clinical practices, treatments and innovative technologies. It presents insights from dermatologists on the changes in dermatology, medical education and technology, as well as changes in patient interactions, importance of mentoring, impact of the journal on dermatology practices, and changes that occurred during and after the pandemic.

The article discusses the use of artificial intelligence (AI) in dermatology for the detection of rare dermatologic diseases. Cited are how OM1's Patient Finder technology can help collect cohort data of rare diseases to improve digital phenotyping and decrease the delay in diagnosis, the capabilities of AI in generalized pustular psoriasis, and the common concerns among clinicians with so many AI platforms available.

The article explores the importance of multidisciplinary approach to improving basal cell carcinoma (BCC) management and treatment. Topics discussed include root causes of delays in diagnosis and care of patients with BCC such as reluctance to pursue surgery and refusal to seek care or treatment, benefits multidisciplinary care and collaboration for BCC patients, and considerations for selection of systemic therapy like hedgehog pathway inhibitor and the immunotherapy drug cemiplimab.

The article focuses on a roundtable discussion on treatments for adult patients with vitiligo, which was held in Scottsdale, Arizona. Topics discussed include a case of a professional makeup artist with vitiligo, the initial steps in managing the patient's condition, and the importance of regular follow-ups in monitoring the patient's progress.

The article explores insights from a pediatric dermatologist, named Benjamin, on the management of vitiligo in both pediatric and adult populations. Topics discussed include the case of a female patient with vitiligo and concomitant moderate atopic dermatitis, the treatment plan given to the patient, and treatment adherence as a challenge in managing vitiligo.

The article explores the use of insurance as the first line of defense for dermatologists against malpractice liability. Topics discussed include factors to be considered by dermatologists in purchasing a medical practice policy, the coverage options offered by a business owner's policy, and the goal of asset protection planning.

The article discusses pediatric skin cancer, a neglected but preventable disease. Cited are the incidence and survivability of pediatric melanoma, methods of skin cancer prevention advocated by many pediatric dermatology experts, and the role of parents and guardians in promoting and reinforcing best skin care practices.

The number of basal cell carcinoma (BCC) cases continues to grow, specifically in patients in their 40s, according to panelists of a recent Frontline Forum. The trend in this age group may stem from adverse effects of long-term indoor tanning1 and increased time for outdoor activities without proper sun-protective behaviors. 2 In the custom Frontline Forum discus- sion New Directions in the Management of Basal Cell Carcinoma, the panel shared how to initiate conversations surrounding available treatment options and the potential for treatment resistance with their patients. Lastly, they highlighted the importance of a multidisciplinary team to improve outcomes in the management of patients with BCC. [ABSTRACT FROM AUTHOR]

The article discusses the highlights from the sessions of the 21st Annual South Beach Symposium in Miami Beach, Florida in 2023. Topics discussed include updates and applications of genomics in dermatology, aesthetic procedures for lesbian, gay, bisexual, transgender and queer plus patients and how tirbanibulin improves skin in patients with actinic keratosis.

An interview with dermatologists Neal Bhatia and Melinda Gooderham and physician assistant Lauren Miller is presented. They discuss the safety and efficacy of deucravacitinib for the treatment of adults with plaque psoriasis, management of adverse events, difference of deucravacitinib from other psoriasis therapies such as biologics, topicals or oral medications. They identify considerations when evaluating psoriasis in patients with skin of color and the benefits of deucravacitinib.

The article explains elements that can go into a comprehensive insurance benefits package for medical practice employees as part of dermatologists' commitment to the health and well-being of their teams. Different health insurance options include comprehensive health coverage, specialized health plans, and wellness and preventive care initiatives. Other insurance that could be offered are disability insurance, life insurance, supplemental insurance and general liability insurance.

The article presents financial tips for young practicing dermatologists. Topics discussed include effective strategies for paying off student loans, information on establishing an emergency fund, and ways to maximize retirement account benefits. It also mentioned significance of understanding cash flow and effective budgeting, and importance of securing disability and life insurance.

The article focuses on Janus kinases (JAKs), a group of inflammatory proteins linked to various inflammatory and autoimmune disorders, particularly in dermatology, including alopecia areata. JAK inhibitors, which suppress inflammatory cytokines by targeting the JAK-STAT pathway, have gained prominence in dermatological treatment, with deuruxolitinib emerging as a potential therapy for moderate to severe alopecia areata, receiving breakthrough therapy and fast track designation from the FDA.

The article discusses the types of risks that can threaten a dermatologist's home and home equity and shares strategies and tools that can be used to protect these valuable assets from potential lawsuits. Cited are the use of insurance as the best way to shield the home from inside risks, tools that physicians can use to shield their home and its equity from potential claims, and the protection that homestead protection law in every state provides.

The article announces the issuance by the U.S. Food and Drug Administration (FDA) of an alert to health care professionals and consumers regarding the discovery of counterfeit onabotulinumtoxina (Botox) products in several states that have been administered for cosmetic purposes. Cited are distinguishing features of counterfeit Botox, adverse events associated to counterfeit Botox, and three considerations for dermatology clinicians with regards to Botox products.

The authors reflect on the year-round significance of Melanoma and Skin Cancer Awareness Month and share clinical pearls to best serve skin cancer patients. Cited are the evolution of treatment modalities for skin cancer and the shift in treatment approaches due to the rise of more aggressive tumors, the significance of a comprehensive evaluation and individualized treatment planning, and the importance of routine skin cancer screening in skin cancer prevention.

The article discusses the unique challenges of adult female acne that dermatologists need to understand in order to become the beacons of hope that their patients need. Cited are changes in adult female acne treatment brought by the 2024 American Academy of Dermatology (AAD) acne guideline update, a thorough patient history that can help in identifying adult female acne, and topical treatments for adult female cystic acne.

The article discusses a legal case involving the use of compounded medications in dermatology. Topics include background on the case, reason that dermatologists need to be careful when considering compounding, and the prohibition by the U.S. Federal Food, Drug, and Cosmetic Act (FDCA) of physicians from using compounding prescriptions that are essentially copies of commercially available drugs.

The article explores the management of vitiligo in diverse patient populations. Topics discussed include factors to be considered by dermatology clinicians in managing vitiligo, the challenges in managing vitiligo in pediatric patients, and the importance of addressing comorbidities in adult patients with vitiligo.

The article focuses on pediatric cases of patients with cutaneous manifestations of serious underlying conditions discussed in a presentation by Lisa Weibel, head of pediatric dermatology department at University Children's Hospital Zürich in Switzerland, during the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario. Topics discussed include the significance of dermatologic signs as early indicators of systemic conditions, like Langerhans cell histiocytosis.

An introduction is presented in which the author discusses articles within the issue on various topics, including the common skin conditions before the start of the school year, the use of OX40 inhibition for treating atopic dermatitis, and highlights from the 49th Society for Pediatric Dermatology Annual Meeting held in Toronto, Ontario.

The article presents the views of expert providers on artificial intelligence (AI) in dermatology as of July 2023. When asked on concerns on the potential increased use of AI in healthcare, Renata Block cites the possible heavy reliance on it that clincians lose sight of their profession. Raj Chovatiya states that AI would effect rapid and accurate communication with patients and insurers. Zoe Diana Draelos notes that AI will dominate dermapathology, with humans providing inputs as needed.

The article discusses findings from a study on distinguishing between scabies and atopic dermatitis (AD). Topics include importance of differentiating such dermatologic conditions, important findings revealed by the study including response to treatment and diagnostic modalities, and implications for clinical practice.

The article provides suggestions to dermatologists on the importance of reviewing an employment contract, essential contract clauses to review, reasons to review contract periodically, and options for contract review. Topics discussed include description on employment contracts, and importance for physicians and their counsel to scrutinize crucial clauses when considering an employment contract.

The article focuses on the initiatives of patients and providers in seeking for therapeutic alternatives to benzoyl peroxide (BPO) due to questions about its safety. It reports the petition by testing laboratory Valisure LLC to recall treatments affected by high levels of benzene, and the collaboration of Lindus Health and Acinonyx Bio for the clinical trial of the ACX topical cream for the treatment of inflammatory acne. Expert recommendations for BPO skepticism and alternatives are offered.

An interview with Adewole Adamson, a dermatologist and the director of the melanoma and pigmented lesion clinic at Dell Seton Medical Center at the University of Texas, is presented. Adamson provides his perspective on the Environemntal Working Group's 2024 Guide to Sunscreens. He cites the difference of the sunscreen approval process and regulation between the U.S., Europe and Asia. He raises concerns about sunscreen absorption and shares tips for clinicians on choosing the right sunscreen.

The author offers observation on step therapy and how dermatologists can improve patient care. Topics discussed include disadvantages of step therapy, skin conditions that can have significant impacts on mental health and self-esteem which includes psoriasis, eczema and acne, and less often discussed aspect of nonmedical switching.

The author discusses the business strategy known as buy and bill for medical dermatology, which allows practices to provide essential medications to patients during their visits while managing the complexities of purchasing, billing, reimbursement, and regulatory compliance. Cited are the benefits of incorporating buy and bill into both the cosmetic and medical aspects, and the appropriate incorporation of the strategy that can increase office revenue without changing practice patterns.

The article examines various types of eyelash adornments, particularly false eyelashes and eyelash perming to help a dermatology clinician in assisting patients with an infection near the eye, traction alopecia from repeated application, or allergic contact dermatitis to the adhesive used. Cited are the types of false eyelashes available in the market, how lash perming is conducted, and advise for people who had they eyelashes permed.

The article discusses the role of diets in managing specific diseases such as canine atopic dermatitis and cutaneous adverse food reactions, highlighting the interplay between genetic and environmental factors, the importance of considering nutrient profiles, and the impact of nutrition on patient outcomes. The authors stress the need for interdisciplinary collaboration and open-mindedness in exploring how diets can affect skin conditions.

The article identifies critical areas that dermatologists and their practices should focus on in 2024. These include medical malpractice insurance coverage and tools to protect assets, long-term financial planning and changes in personal life, insurance coverage amounts and premiums for disability and insurance policies, corporate structure of the practice to optimize tax efficiency, and retirement and benefit plan options for individuals and the practice.

The article presents highlights of a discussion between pediatric dermatologist Lisa Swansn and physician assistant Robert Casquejo on the potential of phosphodiesterase-4 (PDE4) inhibitors for treating mild to moderate plaque psoriasis. Topics include challenges and limitations of topical management of psoriasis, and significance of the oral PDE4 inhibitor apremilast being approved for mild to moderate psoriasis.

The article offers update on therapeutic highlights and developments in dermatology in 2024. These include the expected approval of PDE4 inhibitor roflumilast for treatment of seborrheic dermatitis, phase 3 trial on the efficacy of topical isotretinoin for the treatment of X-linked recessive congenital ichthyosis and autosomal recessive lamellar CI, and the U.S. Food and Drug Administration's ban of formaldehyde (FA) and FA-releasing chemicals from hair smoothening/straightening products.

The article examines the 5 factors that can signifcantly impact the financial plan of physicians, including dermatologists, and should therefore incorporate flexibility and resiliency to structure the plan to ensure long-term success. It includes tax rate changes, changes in stock market to help investors understand that portfolio diversification is key to reducing portfolio risk, and changes in liability and how having a comprehensive asset protection planning can help protect wealth.

The article compares physicians to average U.S. investors in several key areas and examines how these factors affect a dermatologist's approach to investing and wealth management. Cited are the income level and tax liability of doctors compared to investors, the challenges of managing a physician's higher-than-average income and net worth as another financial differentiator for wealth planning and investing.

The article discusses the top 5rosacea treatment takeaways from the presentation given by dermatologist Julie Harper at Maui Derm NP+PA Fall 2023, that all dermatology clinicians can put into practice. Topics covered include the multiple types of lesions and signs that rosacea can present, the skin care regimen required by rosacea, and the role mast cells play in rosacea.

The article presents an interview with atopic dermatitis (AD) patient Jenifer Strobeck and family nurse practitioner Lisa Sanglay. Among the issues they discussed include the AD medications that Strobeck have tried, how Sanglay first evaluated Strobeck, and reasons cited by Sanglay why she picked upadacitinib for Strobeck.

The article describes tax-loss harvesting, a tactic which occurs when an investor sells an investment at a loss to offset current or potential future gains on other investment positions, including using a dermatologist case study. Topics discussed include background on tax-loss harvesting, benefit of this strategy, and the need to include tax-loss harvesting in every astute investor's game plan.

The article provides an answer to a question on what to do with a colleague who defamed him online.